MedPath

KAOPECTATE TABLET - 600MG

KAOPECTATE TABLET - 600MG

Discontinued
DIN Number

02229953

Drug Class

Human

Market Date

Jul 24, 1998

Company
HC

johnson & johnson - merck consumer pharmaceuticals of canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02229953
AIG Number0111623002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A07BC04 ATTAPULGITE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ATTAPULGITE (ACTIVATED)Active
Strength: 600 MG
Monograph: ATTAPULGITE (ACTIVATED)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.